Combination of a CpG-oligodeoxynucleotide and a topoisomerase I inhibitor in the therapy of human tumour xenografts.

[1]  D. Rodeberg,et al.  CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  F. Zunino,et al.  Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma models. , 2003, Biochemical pharmacology.

[3]  M. MacFarlane.  TRAIL-induced signalling and apoptosis. , 2003, Toxicology letters.

[4]  F. Zunino,et al.  Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  S. Ménard,et al.  Prevention of spontaneous mammary adenocarcinoma in HER‐2/neu transgenic mice by foreign DNA , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  C. Bucana,et al.  Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel. , 2002, Cancer research.

[7]  Dallas Jones,et al.  Emerging roles of PPARS in inflammation and immunity , 2002, Nature Reviews Immunology.

[8]  G. Hartmann,et al.  Peritumoral CpG DNA Elicits a Coordinated Response of CD8 T Cells and Innate Effectors to Cure Established Tumors in a Murine Colon Carcinoma Model1 , 2002, The Journal of Immunology.

[9]  S. Ménard,et al.  Absence of the CD1 Molecule Up-Regulates Antitumor Activity Induced by CpG Oligodeoxynucleotides in Mice1 , 2002, The Journal of Immunology.

[10]  A. Mantovani,et al.  Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Y. Kawarada,et al.  NK- and CD8+ T Cell-Mediated Eradication of Established Tumors by Peritumoral Injection of CpG-Containing Oligodeoxynucleotides1 , 2001, The Journal of Immunology.

[12]  T. Giese,et al.  Toll‐like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL‐12 , 2001 .

[13]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[14]  J. Ellwart,et al.  Bacterial CpG-DNA Triggers Activation and Maturation of Human CD11c−, CD123+ Dendritic Cells1 , 2001, The Journal of Immunology.

[15]  S. Hoffman,et al.  Interleukin-12- and Gamma Interferon-Dependent Protection against Malaria Conferred by CpG Oligodeoxynucleotide in Mice , 2001, Infection and Immunity.

[16]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[17]  T. Crabtree,et al.  Enhanced Murine Macrophage TNF Receptor Shedding by Cytosine-Guanine Sequences in Oligodeoxynucleotides1 , 2000, The Journal of Immunology.

[18]  G. Weiner,et al.  CpG oligodeoxynucleotides enhance monoclonal antibody therapy of a murine lymphoma. , 2000, Clinical lymphoma.

[19]  Lin Chen,et al.  Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice. , 1999, Cancer research.

[20]  L. Hültner,et al.  Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. , 1999, Journal of immunology.

[21]  D. Vaux,et al.  Signalling by CD95 and TNF receptors: Not only life and death , 1999, Immunology and cell biology.

[22]  K. Heeg,et al.  Immunostimulatory DNA: Sequence‐dependent production of potentially harmful or useful cytokines , 1997, European journal of immunology.

[23]  M. Ratain,et al.  Topoisomerase I Inhibitors. , 1997, The oncologist.

[24]  M. Rothenberg.  Topoisomerase I inhibitors: review and update. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  A. Krieg,et al.  Unmethylated CpG‐containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by several agents: evidence for blockade of apoptosis at a distal signalling step , 1997, Immunology.

[26]  K. Heeg,et al.  Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shock , 1997, European journal of immunology.

[27]  K. Debatin.  Cytotoxic drugs, programmed cell death, and the immune system: defining new roles in an old play. , 1997, Journal of the National Cancer Institute.

[28]  D. Hume,et al.  Macrophages ingest and are activated by bacterial DNA. , 1996, Journal of immunology.

[29]  R. Willemze,et al.  Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. , 1995, Blood.

[30]  L. Liu,et al.  Topoisomerase-targeting antitumor drugs. , 1989, Biochimica et biophysica acta.

[31]  P. Munson,et al.  EXPFIT: a program for simultaneous analysis of families of exponential decay curves. , 1988, Computer methods and programs in biomedicine.

[32]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[33]  A. Krieg,et al.  CpG motifs in bacterial DNA and their immune effects. , 2002, Annual review of immunology.

[34]  I. Fidler,et al.  Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages. , 2000, Cancer research.

[35]  D. Brewster,et al.  Trends in cancer incidence and mortality in Scotland: description and possible explanations. , 1998, British Journal of Cancer.

[36]  N. J. McNally,et al.  United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). , 1998, British Journal of Cancer.